NEW ORLEANS, Sept. 08, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 16, 2017 to file lead plaintiff applications in a securities class action lawsuit against Rayonier Advanced Materials, Inc. (NYSE:RYAM), if they purchased the Company’s shares between October 29, 2014 and August 19, 2015, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of Tennessee.
Get Help
Rayonier investors should visit us at https://www.claimsfiler.com/cases/new-york-se-ryam or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Rayonier and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
Since 2013, despite statements by the Company to the contrary, Rayonier had been experiencing ongoing difficulties with one of its top customers, Eastman Chemical Company (“Eastman”), regarding competitive pricing levels and certain terms of the contract between the companies. Finally, on August 19, 2015, Rayonier revealed the extent of the protracted dispute with Eastman, including that it had filed suit against it the prior week.
On this news, the price of Rayonier shares plummeted 44% to close at $7.62 on extremely heavy trading volume.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Anta Sports Expands Global Footprint With Strategic Puma Stake
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



